Consumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes

Journal of Nutritional Science

Volumn 2, Issue , 2013, Pages 1-10

  Maneerat, Sujira ^a   Lehtinen, Markus J ^b   Childs, Caroline E ^a   Forssten, Sofia D ^b   Alhoniemi, Esa ^c   Tiphaine, Milin ^a   Yaqoob, Parveen ^a   Ouwehand, Arthur C ^b   Rastall, Robert A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b Danisco Finland Oy   (Finland)

^c Pharmatest Services Ltd   (Finland)

Author keywords

Clinical trials; Elderly adults; Prebiotics; Probiotics

Indexed keywords

EID: 84922277304     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2013.31     Document Type: Article

References (49)

1. Biagi E, Candela M, Fairweather-Tait S, et al. (2012) Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 34, 247-267.
2. Hopkins MJ, Sharp R & Macfarlane GT (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48, 198-205.
3. Biagi E, Nylund L, Candela M, et al. (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5, e10667.
4. Claesson MJ, Cusack S, O’Sullivan O, et al. (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108, Suppl. 1, 4586-4591.
5. Mueller S, Saunier K, Hanisch C, et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
6. Rajilic-Stojanovic M, Heilig HG, Molenaar D, et al. (2009) Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11, 1736-1751.
7. Mäkivuokko H, Tiihonen K, Tynkkynen S, et al. (2010) The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br J Nutr 103, 227-234.
8. Woodmansey EJ, McMurdo ME, Macfarlane GT, et al. (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 6113-6122.
9. Mariat D, Firmesse O, Levenez F, et al. (2009) The Firmicutes/ Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9, 123.
10. Fujihashi K & Kiyono H (2009) Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 30, 334-343.
11. Shaw AC, Joshi S, Greenwood H, et al. (2010) Aging of the innate immune system. Curr Opin Immunol 22, 507-513.
12. Shaw AC, Panda A, Joshi SR, et al. (2011) Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev 10, 346-353.
13. Butcher SK, Chahal H, Nayak L, et al. (2001) Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 70, 881-886.
14. Gill HS, Darragh AJ & Cross ML (2001) Optimizing immunity and gut function in the elderly. J Nutr Health Aging 5, 80-91.
15. Rastall RA, Gibson GR, Gill HS, et al. (2005) Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol 52, 145-152.
16. Tiihonen K, Ouwehand AC & Rautonen N (2010) Human intestinal microbiota and healthy ageing. Ageing Res Rev 9, 107-116.
17. Gibson GR, Scott KP, Rastall RA, et al. (2011) Dietary prebiotics:current status and new definition. Food Sci Tech Bull Funct Foods 7, 1-19.
18. Roberfroid MB (1998) Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 80, Suppl., S197-S202.
19. van Dokkum W, Wezendonk B, Srikumar TS et al. (1999) Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53, 1-7.
20. Macfarlane GT, Steed H & Macfarlane S (2008) Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104, 305-344.
21. Watson D, O’Connell Motherway M, Schoterman MH, et al. (2013) Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol 114, 1132-1146.
22. Worthley DL, Le Leu RK, Whitehall VL, et al. (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90, 578-586.
23. Fujimori S, Gudis K, Mitsui K, et al. (2009) A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25, 520-525.
24. Alander M, Mättö J, Kneifel W, et al. (2001) Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Dairy J 11, 817-825.
25. Gill HS, Rutherfurd KJ, Cross ML, et al. (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74, 833-839.
26. Vulevic J, Drakoularakou A, Yaqoob P, et al. (2008) Modulation of the fecal microflora profile and immune function by a novel transgalactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 1438-1446.
27. Bouhnik Y, Raskine L, Simoneau G, et al. (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80, 1658-1664.
28. Ahmed M, Prasad J, Gill H, et al. (2007) Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging 11, 26-31.
29. Hothorn T, Bretz F & Westfall P (2008) Simultaneous inference in general parametric models. Biomed J 50, 346-363.
30. Langendijk PS, Schut F, Jansen GJ, et al. (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genusspecific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61, 3069-3075.
31. Manz W, Amann R, Ludwig W, et al. (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga-Flavobacter-Bacteroides in the natural environment. Microbiology 142, 1097-1106.
32. Franks AH, Harmsen HJ, Raangs GC, et al. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 3336-3345.
33. Harmsen HJM, Elferich P, Schut F, et al. (1999) A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11, 3-12.
34. Harmsen HJ, Wildeboer-Veloo AC, Grijpstra J, et al. (2000) Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 66, 4523-4527.
35. Sghir A, Gramet G, Suau A, et al. (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66, 2263-2266.
36. Suau A, Rochet V, Sghir A, et al. (2001) Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 24, 139-145.
37. Costabile A, Kolida S, Klinder A, et al. (2010) A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr 104, 1007-1017.
38. Mäkelainen H, Forssten S, Saarinen M, et al. (2010) Xylo-oligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model. Benef Microbes 1, 81-91.
39. Ventura M, Reniero R & Zink R (2001) Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 67, 2760-2765.
40. Larsen CN, Nielsen S, Kaestel P, et al. (2006) Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 60, 1284-1293.
41. Davis LM, Martinez I, Walter J, et al. (2010) A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 144, 285-292.
42. Davis LM, Martinez I, Walter J, et al. (2011) Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS ONE 6, e25200.
43. Gill HS, Cross ML, Rutherfurd KJ, et al. (2001) Dietary probiotic supplementation to enhance cellular immunity in the elderly. Br J Biomed Sci 58, 94-96.
44. Gill HS, Rutherfurd KJ & Cross ML (2001) Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21, 264-271.
45. Arunachalam K, Gill HS & Chandra RK (2000) Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 54, 263-267.
46. Schiffrin EJ, Rochat F, Link-Amster H, et al. (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491-497.
47. Chiang BL, Sheih YH, Wang LH, et al. (2000) Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 54, 849-855.
48. Foligne B, Nutten S, Grangette C, et al. (2007) Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13, 236-243.
49. Franceschi C, Capri M, Monti D, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128, 92-105.